tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market
ABUS
Arbutus Biopharma
RESEARCH TOOLSreports

Arbutus Biopharma (ABUS) Ratios

Compare
1,272 Followers

Arbutus Biopharma Ratios

ABUS's free cash flow for Q4 2025 was $0.99. For the 2025 fiscal year, ABUS's free cash flow was decreased by $ and operating cash flow was $-7.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 15.73 15.73 8.15 5.87 4.60
Quick Ratio
 15.73 15.73 8.15 5.87 4.60
Cash Ratio
 3.00 3.00 2.33 1.17 0.94
Solvency Ratio
 -1.84 -1.84 -2.00 -1.86 -1.16
Operating Cash Flow Ratio
 -6.60 -6.60 -4.15 -3.82 -1.08
Short-Term Operating Cash Flow Coverage
 -72.46 -72.46 0.00 0.00 -95.04
Net Current Asset Value
$ 76.41M$ 76.41M$ 92.97M$ 93.64M$ 92.57M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.04 <0.01 0.06 0.06
Debt-to-Equity Ratio
 0.05 0.05 0.01 0.08 0.09
Debt-to-Capital Ratio
 0.05 0.05 0.01 0.08 0.08
Long-Term Debt-to-Capital Ratio
 0.04 0.04 0.00 0.06 0.07
Financial Leverage Ratio
 1.24 1.24 1.35 1.36 1.43
Debt Service Coverage Ratio
 -57.37 -41.44 -499.29 -154.65 -31.60
Interest Coverage Ratio
 -506.26 -278.88 -557.07 -170.16 -37.92
Debt to Market Cap
 <0.01 <0.01 0.00 0.02 0.03
Interest Debt Per Share
 0.02 0.02 <0.01 0.06 0.09
Net Debt to EBITDA
 0.37 0.52 0.51 0.25 0.29
Profitability Margins
Gross Profit Margin
36.23%97.42%100.00%100.00%100.00%
EBIT Margin
-264.93%-192.08%-1130.82%-399.04%-162.19%
EBITDA Margin
-262.33%-189.51%-1108.46%-391.30%-158.54%
Operating Profit Margin
-348.70%-192.08%-1236.74%-430.53%-167.75%
Pretax Profit Margin
-237.88%-237.88%-1133.04%-401.57%-166.62%
Net Profit Margin
-237.88%-237.88%-1133.04%-401.57%-178.01%
Continuous Operations Profit Margin
-237.88%-237.88%-1133.04%-401.57%-178.01%
Net Income Per EBT
100.00%100.00%100.00%100.00%106.84%
EBT Per EBIT
68.22%123.84%91.62%93.27%99.32%
Return on Assets (ROA)
-35.41%-35.41%-53.09%-50.45%-35.54%
Return on Equity (ROE)
-42.39%-43.75%-71.81%-68.71%-50.75%
Return on Capital Employed (ROCE)
-55.42%-30.53%-65.74%-64.06%-40.27%
Return on Invested Capital (ROIC)
-55.08%-30.34%-65.47%-63.84%-40.17%
Return on Tangible Assets
-35.41%-35.41%-53.09%-50.45%-35.54%
Earnings Yield
-4.08%-3.64%-11.52%-17.56%-19.75%
Efficiency Ratios
Receivables Turnover
 8.06 8.06 2.56 10.21 28.86
Payables Turnover
 7.66 0.31 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 440.09 440.09 1.42 2.98 5.73
Asset Turnover
 0.15 0.15 0.05 0.13 0.20
Working Capital Turnover Ratio
 0.16 0.14 0.06 0.16 0.29
Cash Conversion Cycle
 -2.39 -1.13K 142.49 35.73 12.65
Days of Sales Outstanding
 45.28 45.28 142.49 35.73 12.65
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 47.67 1.18K 0.00 0.00 0.00
Operating Cycle
 45.28 45.28 142.49 35.73 12.65
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.21 -0.21 -0.35 -0.52 -0.23
Free Cash Flow Per Share
 -0.21 -0.21 -0.35 -0.52 -0.24
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
 -9.91M 0.00 -356.32 -85.25 -69.05
Capital Expenditure Coverage Ratio
 -9.91M 0.00 -356.32 -85.25 -69.05
Operating Cash Flow Coverage Ratio
 -9.46 -9.46 -50.31 -9.85 -2.82
Operating Cash Flow to Sales Ratio
 -2.81 -2.81 -10.51 -4.74 -0.91
Free Cash Flow Yield
-4.80%-4.30%-10.71%-20.96%-10.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -24.54 -27.51 -8.68 -5.70 -5.06
Price-to-Sales (P/S) Ratio
 58.64 65.44 98.35 22.87 9.01
Price-to-Book (P/B) Ratio
 10.73 12.04 6.23 3.91 2.57
Price-to-Free Cash Flow (P/FCF) Ratio
 -20.83 -23.25 -9.33 -4.77 -9.81
Price-to-Operating Cash Flow Ratio
 -20.74 -23.25 -9.36 -4.83 -9.95
Price-to-Earnings Growth (PEG) Ratio
 -1.35 0.50 0.64 1.31 0.14
Price-to-Fair Value
 10.73 12.04 6.23 3.91 2.57
Enterprise Value Multiple
 -21.98 -34.01 -8.36 -5.60 -5.39
Enterprise Value
 812.00M 907.77M 571.90M 397.34M 333.46M
EV to EBITDA
 -21.98 -34.01 -8.36 -5.60 -5.39
EV to Sales
 57.66 64.46 92.68 21.90 8.55
EV to Free Cash Flow
 -20.49 -22.90 -8.79 -4.57 -9.30
EV to Operating Cash Flow
 -20.49 -22.90 -8.82 -4.62 -9.43
Tangible Book Value Per Share
 0.40 0.40 0.52 0.64 0.91
Shareholders’ Equity Per Share
 0.40 0.40 0.52 0.64 0.91
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 -0.07
Revenue Per Share
 0.07 0.07 0.03 0.11 0.26
Net Income Per Share
 -0.17 -0.17 -0.38 -0.44 -0.46
Tax Burden
 1.00 1.00 1.00 1.00 1.07
Interest Burden
 0.90 1.24 1.00 1.01 1.03
Research & Development to Revenue
 1.79 1.79 8.76 4.06 2.16
SG&A to Revenue
 1.13 1.13 3.58 1.24 0.46
Stock-Based Compensation to Revenue
 1.47 0.49 1.46 0.51 0.18
Income Quality
 1.18 1.18 0.93 1.18 0.51
Currency in USD